• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CLOVES综合征的皮肤和肌肉骨骼表现综述

A Review on Cutaneous and Musculoskeletal Manifestations of CLOVES Syndrome.

作者信息

Öztürk Durmaz Emel, Demircioğlu Deniz, Yalınay Dikmen Pınar, Alanay Yasemin, Alanay Ahmet, Demirkesen Cüyan, Tokat Fatma, Karaarslan Ercan

机构信息

Department of Dermatology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, İstanbul, Turkey.

Department of Neurology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, İstanbul, Turkey.

出版信息

Clin Cosmet Investig Dermatol. 2022 Apr 13;15:621-630. doi: 10.2147/CCID.S351637. eCollection 2022.

DOI:10.2147/CCID.S351637
PMID:35444443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9013705/
Abstract

CLOVES syndrome is a novel sporadic mosaic segmental overgrowth syndrome, currently categorized under the canopy of PROS (-related overgrowth spectrum) disorders. All PROS disorders harbor heterozygous postzygotic activating somatic mutations involving the gene. As an upstream regulator of the signal transduction pathway, activating mutations of gene commence in uncontrolled growth of cutaneous, vascular (capillaries, veins, and lymphatics), adipose, neural, and musculoskeletal tissues. The excessive growth is segmental, patchy, asymmetric, and confined to body parts affected by the mutation. The term 'CLOVES' is an acronym denoting congenital lipomatous overgrowth, vascular malformations, epidermal nevi and spinal (scoliosis) and/ or skeletal anomalies. The syndrome is characterized by an admixture of overgrown tissues, derived mainly from mesoderm and neuroectoderm. Among PROS disorders, CLOVES syndrome represents the extreme end of the spectrum with massive affection of almost the entire body. The syndrome might judiciously be treated with medications hampering with the signal transduction pathway. This article aims at reviewing the cutaneous and musculoskeletal manifestations of CLOVES syndrome, as the paradigm for PROS disorders. CLOVES syndrome and other PROS disorders are still misdiagnosed, underdiagnosed, underreported, and undertreated by the dermatology community.

摘要

CLOVES综合征是一种新型的散发性嵌合节段性过度生长综合征,目前归类于PROS(相关过度生长谱系)疾病范畴。所有PROS疾病都存在涉及该基因的杂合子合子后激活体细胞突变。作为信号转导通路的上游调节因子,该基因突变的激活始于皮肤、血管(毛细血管、静脉和淋巴管)、脂肪、神经和肌肉骨骼组织的不受控制的生长。过度生长是节段性的、斑片状的、不对称的,且局限于受突变影响的身体部位。“CLOVES”一词是一个首字母缩略词,代表先天性脂肪瘤样过度生长、血管畸形、表皮痣以及脊柱(脊柱侧弯)和/或骨骼异常。该综合征的特征是主要源自中胚层和神经外胚层的过度生长组织的混合。在PROS疾病中,CLOVES综合征代表了几乎累及全身的极端情况。该综合征可以明智地使用阻碍信号转导通路的药物进行治疗。本文旨在综述CLOVES综合征的皮肤和肌肉骨骼表现,作为PROS疾病的范例。CLOVES综合征和其他PROS疾病仍然被皮肤科界误诊、漏诊、报告不足和治疗不足。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/514fd36c8422/CCID-15-621-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/5b7792ddead1/CCID-15-621-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/6288d65402b3/CCID-15-621-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/5bf6aa850536/CCID-15-621-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/8e9538e50873/CCID-15-621-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/374c62afc75f/CCID-15-621-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/fd83afee2b13/CCID-15-621-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/514fd36c8422/CCID-15-621-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/5b7792ddead1/CCID-15-621-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/6288d65402b3/CCID-15-621-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/5bf6aa850536/CCID-15-621-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/8e9538e50873/CCID-15-621-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/374c62afc75f/CCID-15-621-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/fd83afee2b13/CCID-15-621-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc0b/9013705/514fd36c8422/CCID-15-621-g0007.jpg

相似文献

1
A Review on Cutaneous and Musculoskeletal Manifestations of CLOVES Syndrome.CLOVES综合征的皮肤和肌肉骨骼表现综述
Clin Cosmet Investig Dermatol. 2022 Apr 13;15:621-630. doi: 10.2147/CCID.S351637. eCollection 2022.
2
-Related Overgrowth Spectrum相关过度生长谱系
3
-Related Overgrowth Spectrum From Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated With Alpelisib.从诊断到靶向治疗的相关过度生长谱系:1例使用阿培利司治疗的 CLOVES 综合征病例
Front Pediatr. 2021 Sep 9;9:732836. doi: 10.3389/fped.2021.732836. eCollection 2021.
4
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).在体外,变构 AKT 抑制剂 ARQ 092 对源自 PIK3CA 相关过度生长谱(PROS)患者的原代成纤维细胞的疗效。
Neurogenetics. 2018 May;19(2):77-91. doi: 10.1007/s10048-018-0540-1. Epub 2018 Mar 16.
5
CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).CLOVES综合征:PIK3CA相关过度生长谱系(PROS)综述。
Clin Genet. 2017 Jan;91(1):14-21. doi: 10.1111/cge.12832. Epub 2016 Aug 3.
6
[PIK3CA-related overgrowth syndrome (PROS)].[磷脂酰肌醇-3激酶催化亚基α相关过度生长综合征(PROS)]
Nephrol Ther. 2017 Apr;13 Suppl 1:S155-S156. doi: 10.1016/j.nephro.2017.02.004.
7
PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.PIK3CA相关过度生长谱系(PROS):诊断及检测适用标准、鉴别诊断与评估
Am J Med Genet A. 2015 Feb;167A(2):287-95. doi: 10.1002/ajmg.a.36836. Epub 2014 Dec 31.
8
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.PIK3CA相关过度生长谱系的临床描述及自然病史。
Am J Med Genet A. 2014 Jul;164A(7):1713-33. doi: 10.1002/ajmg.a.36552. Epub 2014 Apr 29.
9
Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.PIK3CA相关过度生长谱系(PROS)患者中三种不同合子后突变的分子与功能特征:对PI3K/AKT/mTOR信号传导及对PI3K抑制剂敏感性的影响
PLoS One. 2015 Apr 27;10(4):e0123092. doi: 10.1371/journal.pone.0123092. eCollection 2015.
10
Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes.通过检测培养羊水中的镶嵌性PIK3CA突变确诊CLOVES综合征的产前诊断。
Am J Med Genet A. 2014 Oct;164A(10):2633-7. doi: 10.1002/ajmg.a.36672. Epub 2014 Jul 14.

引用本文的文献

1
Exploring Prenatal Signs of Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Skeletal Anomalies (CLOVES) Syndrome: A Case Report and Literature Review.探索先天性脂肪瘤过度生长、血管畸形、表皮痣和骨骼异常(CLOVES)综合征的产前体征:一例报告及文献综述
Cureus. 2025 Jul 21;17(7):e88455. doi: 10.7759/cureus.88455. eCollection 2025 Jul.
2
Work-Up and Treatment Strategies for Individuals with -Related Disorders: A Consensus of Experts from the Scientific Committee of the Italian Macrodactyly and PROS Association.与肢端肥大症相关障碍患者的评估和治疗策略:来自意大利肢端肥大症和 PROS 协会科学委员会专家的共识。
Genes (Basel). 2023 Nov 27;14(12):2134. doi: 10.3390/genes14122134.
3

本文引用的文献

1
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study.低剂量 PI3K 抑制剂 taselisib 在患有 CLOVES 和 Klippel-Trenaunay 综合征(KTS)的成年患者中的安全性和疗效:TOTEM 试验,一项 1/2 期、多中心、开放标签、单臂研究。
Genet Med. 2021 Dec;23(12):2433-2442. doi: 10.1038/s41436-021-01290-y. Epub 2021 Aug 12.
2
A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations.PIK3CA 相关血管病变疾病发病机制的综述
Orphanet J Rare Dis. 2021 Jul 8;16(1):306. doi: 10.1186/s13023-021-01929-8.
3
Klippel-Trenaunay Syndrome, Segmental/Focal Overgrowth Malformations: A Review.
克-特综合征,节段性/局灶性过度生长畸形:综述
Children (Basel). 2023 Aug 21;10(8):1421. doi: 10.3390/children10081421.
4
Ultrasound Accelerated Catheter Directed Thrombolytic Therapy in a 15-Year-old Pulmonary Embolism Patient with CLOVES Syndrome.超声加速导管定向溶栓治疗一名患有 CLOVES 综合征的 15 岁肺栓塞患者
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296221149986. doi: 10.1177/10760296221149986.
PIK3CA-related overgrowth spectrum: animal model and drug discovery.
PIK3CA 相关过度生长谱:动物模型与药物发现。
C R Biol. 2021 Jul 2;344(2):189-201. doi: 10.5802/crbiol.50.
4
Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.PIK3CA 基因的体细胞框移突变通过触发 PI3K/AKT/mTOR 通路引起 CLOVES 综合征。
Hereditas. 2021 Jun 1;158(1):18. doi: 10.1186/s41065-021-00184-y.
5
Teaching NeuroImages: CLOVES Syndrome.教学神经影像:CLOVES综合征。
Neurology. 2021 Mar 9;96(10):e1487-e1488. doi: 10.1212/WNL.0000000000010856. Epub 2020 Dec 1.
6
Clinical Profile of Overgrowth Syndromes Consistent with PROS (-Related Overgrowth Syndromes)-A Case Series.与PROS(相关过度生长综合征)一致的过度生长综合征的临床特征——病例系列
Indian Dermatol Online J. 2020 Sep 19;11(5):738-746. doi: 10.4103/idoj.IDOJ_520_19. eCollection 2020 Sep-Oct.
7
Overgrowth Syndromes-Evaluation, Diagnosis, and Management.过度生长综合征——评估、诊断与管理
Front Pediatr. 2020 Oct 30;8:574857. doi: 10.3389/fped.2020.574857. eCollection 2020.
8
Unique Case of Congenital Lipomatous Overgrowth With Vascular Malformations, Epidermal Nevi, and Skeletal/Spinal Anomalies Syndrome in a Pediatric Patient.一名儿科患者患先天性脂肪瘤过度生长伴血管畸形、表皮痣和骨骼/脊柱异常综合征的独特病例。
Cureus. 2020 Sep 30;12(9):e10737. doi: 10.7759/cureus.10737.
9
Mechanochemical and surgical ablation of an anomalous upper extremity marginal vein in CLOVES syndrome identifies as the culprit gene mutation.在CLOVES综合征中,对一条异常上肢边缘静脉进行机械化学和手术消融,确定 为致病基因突变。 (你提供的原文此处似乎有信息缺失)
J Vasc Surg Cases Innov Tech. 2020 Jun 25;6(3):438-442. doi: 10.1016/j.jvscit.2020.05.013. eCollection 2020 Sep.
10
Rheumatoid Arthritis and CLOVES Syndrome: A Tricky Diagnosis.类风湿关节炎与CLOVES综合征:一个棘手的诊断
Diagnostics (Basel). 2020 Jul 9;10(7):467. doi: 10.3390/diagnostics10070467.